Pulse.

a daily field guide to health research that matters

◆ Console

‹ Tue · 7 Jul 2026
Early cancer detection or prevention

Serum miR-181a-5p, miR-214-3p, and miR-223-3p in epithelial ovarian cancer.

Early detection of epithelial ovarian cancer (EOC) remains challenging due to nonspecific symptoms and limitations of current biomarkers. Serum miR-181a-5p and miR-223-3p are significantly downregulated in EOC and exhibit moderate discriminatory capacity, suggesting that they may warrant further evaluation as components of future multimodal biomarker strategies.

Early detection of epithelial ovarian cancer (EOC) remains challenging due to nonspecific symptoms and limitations of current biomarkers. Serum miR-181a-5p and miR-223-3p are significantly downregulated in EOC and exhibit moderate discriminatory capacity, suggesting that they may warrant further evaluation as components of future multimodal biomarker strategies.

What the study was

Study design
Case-control study
Sample size
77
Category
Early Detection
Maturity
Exploratory
Journal
Scientific reports

Why it surfaced

Relevant Early cancer detection study (early cancer detection relevance) meets standard-priority threshold.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.